2018年8月9日

05:24美国东部时间2018年8月9日| BioPortfolio报告总结Neuraltus制药公司Neuraltus生物制药公司,开发和独占鳌头神经退行性疾病的治疗。公司提供的产品在临床开发,包括NP001等等。发展巨噬细胞基于最近的理解基本的慢性神经退行性疾病的炎症和巨噬细胞的激活作用。公司的产品用于治疗肌萎缩性脊髓侧索硬化症等神经退行性疾病,帕金森的疾病,老年痴呆症和继承metaboloic障碍如法布瑞氏症和高歇氏病。Neuraltus总部位于圣布鲁诺,加州,美国。Neuraltus制药公司药品医疗交易和联盟为您提供全面的数据和趋势分析公司并购的MAs,伙伴关系和融资。报告提供详细信息的并购,股票/债券发行、私募股权、风险融资和合作公司交易记录的一个五年计划。报告提出了详细的比较数据,交易数量和他们的价值分为交易类型,界别分组和地区。GlobalData这份报告中给出的数据来自内部专有的制药eTrack交易数据库,和小学和中学的研究。金融交易的分析公司的财务交易范围包括并购、股票/债券发行、私募股权、风险融资和合作关系。 Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News